Clinical trial
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-121
NCT04597385 is registered in ClinicalTrials.gov with REGENXBIO Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-121
- Lead sponsor
- REGENXBIO Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 14, 2021
- Completion date
- October 31, 2028
- Enrollment
- 27 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.